| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Positive-Pressure Respiration | 28 | 2021 | 1160 | 3.48 | Why? |
| Receptors, Odorant | 6 | 2018 | 23 | 2.74 | Why? |
| Ventilator-Induced Lung Injury | 7 | 2021 | 260 | 1.79 | Why? |
| Respiration, Artificial | 34 | 2021 | 22116 | 1.68 | Why? |
| Anesthesia | 6 | 2021 | 1236 | 1.33 | Why? |
| Tracheostomy | 9 | 2021 | 1963 | 1.25 | Why? |
| Anesthesia, General | 4 | 2018 | 470 | 1.19 | Why? |
| Postoperative Complications | 15 | 2019 | 5861 | 1.18 | Why? |
| Insect Proteins | 3 | 2018 | 39 | 1.00 | Why? |
| Tracheotomy | 2 | 2018 | 427 | 0.97 | Why? |
| Intraoperative Care | 4 | 2019 | 238 | 0.95 | Why? |
| Odorants | 3 | 2018 | 219 | 0.95 | Why? |
| Pheromones | 3 | 2018 | 7 | 0.92 | Why? |
| Tidal Volume | 14 | 2019 | 565 | 0.81 | Why? |
| Albuterol | 2 | 2018 | 105 | 0.80 | Why? |
| Airway Resistance | 2 | 2019 | 83 | 0.76 | Why? |
| One-Lung Ventilation | 1 | 2018 | 53 | 0.70 | Why? |
| Respiratory Mechanics | 6 | 2021 | 585 | 0.68 | Why? |
| Neuromuscular Blocking Agents | 1 | 2018 | 121 | 0.68 | Why? |
| Rest | 1 | 2018 | 188 | 0.66 | Why? |
| Insecta | 1 | 2017 | 122 | 0.65 | Why? |
| Perioperative Care | 5 | 2019 | 1329 | 0.64 | Why? |
| Obesity | 6 | 2019 | 7388 | 0.63 | Why? |
| Nebulizers and Vaporizers | 2 | 2018 | 497 | 0.62 | Why? |
| Lung | 20 | 2021 | 31049 | 0.58 | Why? |
| Respiratory Insufficiency | 8 | 2021 | 7301 | 0.57 | Why? |
| Locusta migratoria | 1 | 2013 | 1 | 0.55 | Why? |
| Gonads | 1 | 2013 | 17 | 0.54 | Why? |
| Intensive Care Units | 21 | 2021 | 29594 | 0.53 | Why? |
| Ventilators, Mechanical | 4 | 2019 | 2193 | 0.53 | Why? |
| Postoperative Care | 1 | 2018 | 755 | 0.50 | Why? |
| Monitoring, Physiologic | 4 | 2019 | 1956 | 0.49 | Why? |
| Pulmonary Atelectasis | 3 | 2021 | 80 | 0.49 | Why? |
| Hemodynamics | 6 | 2018 | 1562 | 0.48 | Why? |
| Postoperative Period | 3 | 2018 | 651 | 0.47 | Why? |
| Respiration Disorders | 1 | 2018 | 526 | 0.46 | Why? |
| Critical Care | 12 | 2021 | 14081 | 0.46 | Why? |
| Physical Therapy Modalities | 1 | 2020 | 1090 | 0.45 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.44 | Why? |
| Acute Lung Injury | 5 | 2021 | 904 | 0.44 | Why? |
| Continuous Positive Airway Pressure | 2 | 2018 | 1187 | 0.44 | Why? |
| Noninvasive Ventilation | 4 | 2021 | 2329 | 0.43 | Why? |
| Critical Illness | 16 | 2021 | 17281 | 0.41 | Why? |
| Rats, Wistar | 10 | 2019 | 621 | 0.38 | Why? |
| Abdomen | 5 | 2018 | 424 | 0.38 | Why? |
| Survivors | 3 | 2021 | 2619 | 0.38 | Why? |
| Lung Diseases | 5 | 2019 | 2361 | 0.35 | Why? |
| Arthropod Proteins | 2 | 2018 | 31 | 0.34 | Why? |
| Anesthetics | 3 | 2020 | 196 | 0.34 | Why? |
| Intra-Abdominal Hypertension | 2 | 2017 | 36 | 0.34 | Why? |
| Biosensing Techniques | 2 | 2018 | 2116 | 0.34 | Why? |
| Bariatric Surgery | 1 | 2018 | 1298 | 0.33 | Why? |
| Extracellular Matrix Proteins | 1 | 2007 | 95 | 0.33 | Why? |
| Extracellular Matrix | 1 | 2007 | 189 | 0.30 | Why? |
| Gene Expression Regulation | 3 | 2019 | 4020 | 0.30 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.30 | Why? |
| Glutamine | 2 | 2019 | 111 | 0.29 | Why? |
| Pulmonary Edema | 2 | 2019 | 430 | 0.28 | Why? |
| Humans | 101 | 2021 | 930598 | 0.28 | Why? |
| Rats | 11 | 2019 | 2764 | 0.28 | Why? |
| Candidemia | 2 | 2020 | 353 | 0.27 | Why? |
| Patient Outcome Assessment | 2 | 2019 | 707 | 0.27 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.27 | Why? |
| Intubation, Intratracheal | 3 | 2018 | 3962 | 0.26 | Why? |
| Respiration | 4 | 2021 | 729 | 0.25 | Why? |
| Surgical Procedures, Operative | 1 | 2018 | 2662 | 0.24 | Why? |
| Collagen | 2 | 2021 | 222 | 0.24 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.23 | Why? |
| Randomized Controlled Trials as Topic | 7 | 2019 | 10649 | 0.22 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.22 | Why? |
| Pulmonary Gas Exchange | 2 | 2021 | 414 | 0.22 | Why? |
| Models, Biological | 2 | 2017 | 4907 | 0.22 | Why? |
| Anti-Inflammatory Agents | 4 | 2020 | 6153 | 0.22 | Why? |
| Ligands | 2 | 2018 | 1300 | 0.22 | Why? |
| Blood Volume | 1 | 2021 | 90 | 0.22 | Why? |
| Random Allocation | 6 | 2018 | 773 | 0.21 | Why? |
| Pulmonary Alveoli | 3 | 2021 | 867 | 0.21 | Why? |
| Meninges | 1 | 2019 | 40 | 0.20 | Why? |
| Double-Blind Method | 3 | 2021 | 5988 | 0.20 | Why? |
| Fibrosis | 2 | 2020 | 800 | 0.20 | Why? |
| Out-of-Hospital Cardiac Arrest | 3 | 2018 | 1047 | 0.19 | Why? |
| Tomography | 2 | 2018 | 183 | 0.19 | Why? |
| Methylprednisolone | 2 | 2020 | 2107 | 0.19 | Why? |
| Triage | 1 | 2018 | 7151 | 0.19 | Why? |
| Hypothermia, Induced | 2 | 2018 | 176 | 0.19 | Why? |
| Varroidae | 1 | 2018 | 2 | 0.19 | Why? |
| Rewarming | 1 | 2018 | 11 | 0.19 | Why? |
| Electronic Nose | 1 | 2018 | 36 | 0.19 | Why? |
| Intracranial Pressure | 1 | 2019 | 90 | 0.19 | Why? |
| Pneumonia, Viral | 20 | 2021 | 243684 | 0.19 | Why? |
| Insect Repellents | 1 | 2018 | 23 | 0.19 | Why? |
| Optic Nerve | 1 | 2019 | 123 | 0.18 | Why? |
| Animals | 23 | 2020 | 78931 | 0.18 | Why? |
| Laparotomy | 2 | 2017 | 241 | 0.18 | Why? |
| Anesthesiology | 3 | 2021 | 1163 | 0.18 | Why? |
| Bees | 1 | 2018 | 41 | 0.18 | Why? |
| Hemodynamic Monitoring | 1 | 2018 | 61 | 0.18 | Why? |
| Methyl Ethers | 1 | 2017 | 22 | 0.18 | Why? |
| Anesthesia, Cardiac Procedures | 1 | 2020 | 145 | 0.18 | Why? |
| Water-Electrolyte Imbalance | 1 | 2019 | 119 | 0.17 | Why? |
| Bacteremia | 2 | 2020 | 1372 | 0.17 | Why? |
| Humidifiers | 1 | 2017 | 31 | 0.17 | Why? |
| Phagocytes | 1 | 2018 | 180 | 0.17 | Why? |
| Isoflurane | 1 | 2017 | 38 | 0.17 | Why? |
| Cerebrovascular Circulation | 1 | 2021 | 340 | 0.17 | Why? |
| Arthropod Antennae | 1 | 2016 | 2 | 0.17 | Why? |
| Ventilator Weaning | 3 | 2018 | 536 | 0.17 | Why? |
| Anopheles | 1 | 2018 | 89 | 0.17 | Why? |
| Electric Impedance | 2 | 2017 | 283 | 0.17 | Why? |
| Bone Marrow Cells | 1 | 2018 | 186 | 0.16 | Why? |
| Coronavirus Infections | 17 | 2020 | 253789 | 0.16 | Why? |
| Practice Guidelines as Topic | 6 | 2020 | 15421 | 0.16 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.16 | Why? |
| Dilatation | 1 | 2018 | 181 | 0.16 | Why? |
| Intraoperative Complications | 1 | 2019 | 221 | 0.16 | Why? |
| Ixodes | 1 | 2016 | 58 | 0.16 | Why? |
| Salvage Therapy | 1 | 2019 | 417 | 0.16 | Why? |
| Delphi Technique | 1 | 2021 | 1257 | 0.16 | Why? |
| Internationality | 5 | 2020 | 3297 | 0.15 | Why? |
| Microvessels | 1 | 2020 | 490 | 0.15 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.15 | Why? |
| Dasatinib | 1 | 2015 | 55 | 0.15 | Why? |
| Brain Death | 1 | 2017 | 146 | 0.15 | Why? |
| Acetylcysteine | 1 | 2018 | 255 | 0.15 | Why? |
| beta-Glucans | 1 | 2017 | 176 | 0.15 | Why? |
| Anesthesiologists | 1 | 2021 | 614 | 0.14 | Why? |
| Brain Injuries | 2 | 2017 | 374 | 0.14 | Why? |
| Brain Ischemia | 3 | 2020 | 2813 | 0.14 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.14 | Why? |
| Airway Obstruction | 1 | 2017 | 182 | 0.14 | Why? |
| Reference Standards | 1 | 2019 | 1163 | 0.14 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 2309 | 0.14 | Why? |
| Social Participation | 1 | 2018 | 269 | 0.14 | Why? |
| Male | 41 | 2021 | 367725 | 0.14 | Why? |
| APACHE | 1 | 2017 | 682 | 0.14 | Why? |
| Macrophages, Alveolar | 1 | 2018 | 668 | 0.14 | Why? |
| Tissue Plasminogen Activator | 1 | 2021 | 778 | 0.14 | Why? |
| Multicenter Studies as Topic | 5 | 2018 | 2437 | 0.13 | Why? |
| Animal Communication | 1 | 2013 | 10 | 0.13 | Why? |
| Antiphospholipid Syndrome | 1 | 2020 | 533 | 0.13 | Why? |
| Spirometry | 1 | 2017 | 524 | 0.13 | Why? |
| Fluid Therapy | 1 | 2019 | 628 | 0.13 | Why? |
| Leukocyte Count | 2 | 2021 | 3178 | 0.13 | Why? |
| Administration, Inhalation | 2 | 2018 | 1647 | 0.13 | Why? |
| Treatment Outcome | 17 | 2021 | 51732 | 0.13 | Why? |
| Thoracic Surgical Procedures | 1 | 2019 | 504 | 0.12 | Why? |
| Multiple Organ Failure | 2 | 2020 | 1724 | 0.12 | Why? |
| Spectrometry, Fluorescence | 1 | 2013 | 177 | 0.12 | Why? |
| Female | 39 | 2021 | 380317 | 0.12 | Why? |
| Ultrasonography, Interventional | 1 | 2018 | 560 | 0.12 | Why? |
| Airway Management | 2 | 2020 | 1298 | 0.12 | Why? |
| Advisory Committees | 1 | 2020 | 1418 | 0.12 | Why? |
| Body Temperature | 1 | 2018 | 875 | 0.12 | Why? |
| Aged | 29 | 2021 | 215776 | 0.12 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.12 | Why? |
| Cognition Disorders | 1 | 2018 | 574 | 0.12 | Why? |
| Oxygen | 3 | 2021 | 3715 | 0.12 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.12 | Why? |
| Lung Injury | 2 | 2018 | 919 | 0.12 | Why? |
| Neuroimaging | 1 | 2019 | 1106 | 0.11 | Why? |
| Burns | 1 | 2018 | 466 | 0.11 | Why? |
| Malaria | 1 | 2021 | 1097 | 0.11 | Why? |
| Pulmonary Fibrosis | 1 | 2021 | 1068 | 0.11 | Why? |
| Return to Work | 1 | 2018 | 579 | 0.11 | Why? |
| Carbon Dioxide | 1 | 2018 | 917 | 0.11 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.11 | Why? |
| Blood Gas Analysis | 3 | 2021 | 893 | 0.11 | Why? |
| Middle Aged | 30 | 2021 | 270681 | 0.11 | Why? |
| Cerebrovascular Disorders | 1 | 2019 | 1040 | 0.11 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 595 | 0.11 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.11 | Why? |
| Phenotype | 2 | 2020 | 4037 | 0.11 | Why? |
| Hospital Mortality | 6 | 2021 | 22087 | 0.11 | Why? |
| Congresses as Topic | 1 | 2020 | 1347 | 0.11 | Why? |
| Sequence Homology, Amino Acid | 1 | 2013 | 945 | 0.10 | Why? |
| Pneumonia | 3 | 2019 | 5652 | 0.10 | Why? |
| Inhibitory Concentration 50 | 1 | 2013 | 907 | 0.10 | Why? |
| Robotic Surgical Procedures | 1 | 2018 | 787 | 0.10 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2020 | 9335 | 0.10 | Why? |
| Extracellular Traps | 1 | 2019 | 1036 | 0.10 | Why? |
| Sex Characteristics | 1 | 2018 | 1120 | 0.10 | Why? |
| Tomography, X-Ray Computed | 6 | 2021 | 25144 | 0.10 | Why? |
| Body Mass Index | 3 | 2017 | 4306 | 0.10 | Why? |
| Proteomics | 2 | 2018 | 2481 | 0.10 | Why? |
| Bronchoscopy | 1 | 2018 | 991 | 0.10 | Why? |
| Hot Temperature | 1 | 2017 | 1299 | 0.10 | Why? |
| Brain Diseases | 1 | 2021 | 1463 | 0.10 | Why? |
| Alveolar Epithelial Cells | 1 | 2017 | 1445 | 0.10 | Why? |
| Respiratory Mucosa | 1 | 2018 | 1522 | 0.10 | Why? |
| Lipopolysaccharides | 3 | 2019 | 848 | 0.10 | Why? |
| Fibrinolytic Agents | 1 | 2021 | 1702 | 0.10 | Why? |
| Italy | 10 | 2021 | 38444 | 0.09 | Why? |
| Protein Binding | 2 | 2017 | 11430 | 0.09 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.09 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.09 | Why? |
| Nitriles | 1 | 2013 | 1053 | 0.09 | Why? |
| Peroxidase | 2 | 2019 | 207 | 0.09 | Why? |
| Extracellular Fluid | 1 | 2007 | 19 | 0.09 | Why? |
| Basement Membrane | 1 | 2007 | 30 | 0.09 | Why? |
| Patient Positioning | 1 | 2018 | 1505 | 0.09 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2013 | 881 | 0.09 | Why? |
| Adult | 20 | 2021 | 244371 | 0.09 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.09 | Why? |
| Molecular Sequence Data | 1 | 2013 | 3198 | 0.09 | Why? |
| Betacoronavirus | 15 | 2020 | 204454 | 0.09 | Why? |
| Immunomodulation | 1 | 2016 | 1472 | 0.08 | Why? |
| Neurology | 1 | 2019 | 1613 | 0.08 | Why? |
| Disease Models, Animal | 7 | 2019 | 10998 | 0.08 | Why? |
| Neurosurgical Procedures | 1 | 2019 | 1738 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.08 | Why? |
| Operating Rooms | 1 | 2018 | 1841 | 0.08 | Why? |
| Occupational Stress | 1 | 2020 | 2044 | 0.08 | Why? |
| Kidney Diseases | 1 | 2018 | 1434 | 0.08 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 1322 | 0.08 | Why? |
| Proteome | 1 | 2016 | 1812 | 0.08 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.08 | Why? |
| Wounds and Injuries | 1 | 2019 | 1708 | 0.08 | Why? |
| Risk Factors | 7 | 2020 | 71621 | 0.08 | Why? |
| International Cooperation | 1 | 2019 | 3436 | 0.08 | Why? |
| Time Factors | 6 | 2018 | 31397 | 0.08 | Why? |
| Sample Size | 2 | 2018 | 518 | 0.08 | Why? |
| Nutritional Support | 1 | 2010 | 447 | 0.07 | Why? |
| Pandemics | 21 | 2021 | 389249 | 0.07 | Why? |
| Oxygen Inhalation Therapy | 1 | 2019 | 3629 | 0.07 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.07 | Why? |
| Nurses | 1 | 2020 | 2285 | 0.07 | Why? |
| Protein Kinase Inhibitors | 1 | 2015 | 1585 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
| Statistics, Nonparametric | 2 | 2018 | 1008 | 0.07 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.07 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2018 | 1876 | 0.07 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.07 | Why? |
| Stroke | 2 | 2018 | 8839 | 0.07 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.07 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.06 | Why? |
| Cannula | 2 | 2019 | 750 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Europe | 4 | 2021 | 12702 | 0.06 | Why? |
| Liver Diseases | 1 | 2018 | 2698 | 0.06 | Why? |
| Cell Membrane | 1 | 2007 | 743 | 0.06 | Why? |
| Receptors, CCR6 | 1 | 2021 | 45 | 0.06 | Why? |
| Receptors, CCR4 | 1 | 2021 | 42 | 0.06 | Why? |
| Amino Acid Sequence | 1 | 2013 | 6049 | 0.06 | Why? |
| Lung Volume Measurements | 1 | 2021 | 115 | 0.06 | Why? |
| Enterobacter aerogenes | 1 | 2020 | 24 | 0.06 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.05 | Why? |
| Masks | 2 | 2021 | 8528 | 0.05 | Why? |
| Observational Studies as Topic | 2 | 2018 | 1887 | 0.05 | Why? |
| Length of Stay | 4 | 2021 | 11042 | 0.05 | Why? |
| Apnea | 1 | 2020 | 58 | 0.05 | Why? |
| Nitro Compounds | 1 | 2021 | 190 | 0.05 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 5002 | 0.05 | Why? |
| Glutathione Reductase | 1 | 2019 | 17 | 0.05 | Why? |
| Interleukin-10 | 2 | 2019 | 1409 | 0.05 | Why? |
| Heart Septum | 1 | 2019 | 29 | 0.05 | Why? |
| Enterococcus faecalis | 1 | 2020 | 126 | 0.05 | Why? |
| Interferon-gamma | 2 | 2021 | 2711 | 0.05 | Why? |
| Overnutrition | 1 | 2019 | 18 | 0.05 | Why? |
| Chemotaxis, Leukocyte | 1 | 2019 | 82 | 0.05 | Why? |
| Enterococcus faecium | 1 | 2020 | 95 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Hypocapnia | 1 | 2018 | 19 | 0.05 | Why? |
| Glutathione Peroxidase | 1 | 2019 | 83 | 0.05 | Why? |
| Autopsy | 2 | 2021 | 3495 | 0.05 | Why? |
| Inflammation | 2 | 2019 | 13255 | 0.05 | Why? |
| Endotoxins | 1 | 2019 | 80 | 0.05 | Why? |
| Anesthesia, Intravenous | 1 | 2018 | 37 | 0.05 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Interleukin-6 | 4 | 2018 | 7522 | 0.05 | Why? |
| Intraoperative Period | 1 | 2018 | 97 | 0.05 | Why? |
| Anatomic Landmarks | 1 | 2018 | 44 | 0.05 | Why? |
| Research Design | 2 | 2015 | 5830 | 0.05 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.05 | Why? |
| Chemokine CXCL2 | 1 | 2017 | 21 | 0.05 | Why? |
| Fluorescent Antibody Technique | 1 | 2021 | 835 | 0.04 | Why? |
| Equipment Design | 2 | 2021 | 3095 | 0.04 | Why? |
| Manikins | 1 | 2021 | 466 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Macrophages | 2 | 2021 | 2784 | 0.04 | Why? |
| Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 43 | 0.04 | Why? |
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 44 | 0.04 | Why? |
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 59 | 0.04 | Why? |
| Cadherins | 1 | 2018 | 145 | 0.04 | Why? |
| Controlled Before-After Studies | 1 | 2017 | 51 | 0.04 | Why? |
| Recovery of Function | 2 | 2018 | 2461 | 0.04 | Why? |
| Equivalence Trials as Topic | 1 | 2018 | 242 | 0.04 | Why? |
| Nymph | 1 | 2016 | 11 | 0.04 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.04 | Why? |
| Preoperative Period | 1 | 2018 | 271 | 0.04 | Why? |
| Tachypnea | 1 | 2018 | 197 | 0.04 | Why? |
| Heart Failure | 1 | 2019 | 6638 | 0.04 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.04 | Why? |
| Respiratory Physiological Phenomena | 1 | 2018 | 157 | 0.04 | Why? |
| Phagocytosis | 1 | 2019 | 409 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2017 | 5397 | 0.04 | Why? |
| Hypercapnia | 1 | 2018 | 172 | 0.04 | Why? |
| Blood-Brain Barrier | 1 | 2021 | 531 | 0.04 | Why? |
| Darunavir | 1 | 2020 | 477 | 0.04 | Why? |
| Neutrophil Infiltration | 1 | 2017 | 201 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| HIV Protease Inhibitors | 1 | 2020 | 434 | 0.04 | Why? |
| Hypovolemia | 1 | 2017 | 65 | 0.04 | Why? |
| Proteoglycans | 1 | 2017 | 130 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2020 | 17020 | 0.04 | Why? |
| Operative Time | 1 | 2018 | 450 | 0.04 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2020 | 323 | 0.04 | Why? |
| Glasgow Coma Scale | 1 | 2017 | 249 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Thiazoles | 1 | 2021 | 496 | 0.04 | Why? |
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 220 | 0.04 | Why? |
| Evidence-Based Medicine | 2 | 2020 | 3228 | 0.04 | Why? |
| Pressure | 1 | 2018 | 289 | 0.04 | Why? |
| Tight Junctions | 1 | 2017 | 179 | 0.04 | Why? |
| Pseudomonas Infections | 1 | 2020 | 425 | 0.04 | Why? |
| Materials Testing | 1 | 2018 | 380 | 0.04 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.04 | Why? |
| Pseudomonas aeruginosa | 1 | 2020 | 652 | 0.04 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
| Streptococcus pneumoniae | 1 | 2020 | 827 | 0.04 | Why? |
| Goals | 1 | 2018 | 335 | 0.04 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.03 | Why? |
| Respiratory Rate | 1 | 2019 | 691 | 0.03 | Why? |
| Survival Rate | 2 | 2020 | 9206 | 0.03 | Why? |
| Critical Care Nursing | 1 | 2020 | 469 | 0.03 | Why? |
| Enterobacteriaceae Infections | 1 | 2020 | 529 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Sick Leave | 1 | 2018 | 318 | 0.03 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.03 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
| Pneumococcal Infections | 1 | 2020 | 562 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2018 | 711 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2020 | 844 | 0.03 | Why? |
| RNA, Messenger | 2 | 2018 | 5131 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Neutrophils | 2 | 2021 | 5476 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| DNA | 1 | 2019 | 778 | 0.03 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2019 | 1136 | 0.03 | Why? |
| Laryngoscopy | 1 | 2018 | 413 | 0.03 | Why? |
| Transforming Growth Factor beta | 1 | 2015 | 363 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.03 | Why? |
| Flow Cytometry | 1 | 2021 | 2393 | 0.03 | Why? |
| Vascular Surgical Procedures | 1 | 2021 | 882 | 0.03 | Why? |
| Swine | 2 | 2012 | 3352 | 0.03 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 800 | 0.03 | Why? |
| Airway Extubation | 1 | 2017 | 403 | 0.03 | Why? |
| Cell Survival | 1 | 2017 | 1581 | 0.03 | Why? |
| Toll-Like Receptor 4 | 1 | 2015 | 390 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Elective Surgical Procedures | 2 | 2020 | 5338 | 0.03 | Why? |
| A549 Cells | 1 | 2017 | 2066 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.03 | Why? |
| Lung Compliance | 1 | 2012 | 243 | 0.03 | Why? |
| Creatinine | 1 | 2017 | 1443 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Asia | 1 | 2018 | 2399 | 0.03 | Why? |
| Staphylococcal Infections | 1 | 2020 | 1099 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2015 | 604 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.03 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.03 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.02 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
| Health Surveys | 1 | 2020 | 2841 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.02 | Why? |
| Dexamethasone | 1 | 2020 | 2055 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2019 | 5814 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.02 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Videoconferencing | 1 | 2020 | 2081 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.02 | Why? |
| Laparoscopy | 1 | 2018 | 1532 | 0.02 | Why? |
| Immunotherapy | 1 | 2020 | 2421 | 0.02 | Why? |
| Models, Animal | 1 | 2010 | 788 | 0.02 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Netherlands | 1 | 2015 | 3533 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Emotions | 1 | 2018 | 2418 | 0.02 | Why? |
| Respiratory System | 1 | 2018 | 3213 | 0.02 | Why? |
| Health Status | 1 | 2018 | 3259 | 0.02 | Why? |
| Australia | 1 | 2018 | 6306 | 0.02 | Why? |
| Patient Care Team | 1 | 2019 | 3556 | 0.02 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2015 | 5542 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
| Clinical Protocols | 1 | 2015 | 2734 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Spain | 1 | 2021 | 15545 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.01 | Why? |
| Radiography | 1 | 2010 | 1576 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Patient Selection | 1 | 2015 | 4560 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2016 | 6331 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| Germany | 1 | 2010 | 9196 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |